Common Drugs against Herpes Virus Stopped Working; CBCD Reviews Scientific Studies

“Infected with the herpes virus (HSV)? We recommend Gene-Eden-VIR or Novirin.” – John Evans, CBCD

Standard drugs commonly used against the herpes virus are becoming less effective. The reason is a phenomenon called “drug resistance.” The NIH defines drug resistance as “the ability of microbes, such as bacteria, viruses, parasites, or fungi, to grow in the presence of a chemical (drug) that would normally kill it or limit its growth.” (1) Doctors Andrei and Snoeck say that “HSV drug-resistance should be taken into account not only in immunocompromised individuals but also in immunocompetent persons.” (2) That is, the doctors urge the medical community to consider drug resistance in the treatment of people with a healthy immune system and people who have a weak immune system.  Doctors Andrei and Snoeck are from the Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, in Belgium.

The Center for the Biology of Chronic Disease (CBCD) therefore recommends that individuals take Gene-Eden-VIR or Novirin against the latent HSV. These natural alternatives have a formula that was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against HSV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with HSV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (3) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3) In addition, this natural antiviral was recently proven to reduce mental and physical fatigue in a post-marketing clinical study that followed FDA guidelines.

Both products can be ordered online on the Gene-Eden-VIR and Novirin websites.

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.

Scientists used to think that an infection with a drug resistant strain is rare in people with a healthy immune system. However, recent research showed that HSV drug resistant strains are becoming more common especially when the virus infects “immune privileged” sites. For example, Doctors Andrei and Snoeck wrote that drug resistant strains of herpes should be suspected in cases of “unresponsive herpetic keratitis (a viral infection of the eye) and herpes simplex encephalitis (an infection of the brain).” (2)

The CBCD proposes that as a reaction to this increase in drug resistance, individuals and the medical community should begin to consider natural HSV remedies.

References:

(1) The National Institute of Allergy and Infectious Diseases. Last updated February 18, 2009.

(2) Andrei G, Snoeck R. Herpes simplex virus drug-resistance: new mutations and insights. Curr Opin Infect Dis. 2013 Dec;26(6):551-60.

(3) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8 https://dx.doi.org/10.4236/pp.2013.46A001

About CBCD

About CBCD

The Center for the Biology of Chronic Disease (https://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.